Products & Reviews

Owing to the importance of in vitro screening and target validation during the early stages of antibody discovery, Sino Biological has established in vitro activity assay platforms for streamlining antibody drug development projects.

Sino Biological provides comprehensive reagents and services for CAR-NK cell therapy development to support our customers from early target discovery to the preclinical phase of research and development.

Sino Biological offers a comprehensive array of recombinant cytokines tailored for cell culture to advance research in tumor immunotherapy, stem cell therapy, drug screening, and regenerative medicine. With stringent quality control and extensive validation, we guarantee that our cytokines have high purity, validated biological activity, high stability, and low endotoxin levels.

Sino Biological offers a series of high-quality cytokines with high activity, low endotoxin, high batch-to-batch consistency, and high purity. These cytokines support various applications, including immune cell culture, immune cell therapy, drug development, and vaccine research.

Cytokines play a pivotal role in stem cell renewal and differentiation. To support stem cell research, Sino Biological offers a wide range of high-quality and GMP-grade recombinant cytokines with high bioactivity, high lot-to-lot consistency, and high purity.

Cytokines and their receptors show great potential in tumor immunotherapy, and many cytokines have been identified as targets for tumor drug development. Sino Biological's cytokines support stem cells, neural cells, immune cells, and organoids, facilitating functional studies and accelerating scientific discoveries.

Sino Biological has developed an extensive suite of recombinant complement proteins, covering C1s, C2, C3, C5, C7, Factor B, D, H, I and more, advancing the development of novel treatments targeting complement proteins.

Sino Biological offers a comprehensive range of recombinant HER3 proteins and antibodies, facilitating studies on HER3 signaling, protein-protein interactions, and drug efficacy assessments.

Sino Biological provides a comprehensive range of recombinant CEACAM proteins and corresponding CEACAM antibodies for crucial research, aiding investigations into CEACAM interactions with pathogens and their potential in new medical discoveries.

Sino Biological is focused on developing multi-pass transmembrane protein products and has set up three platforms to provide important raw materials for early-stage drug development. These platforms include virus-like particles (VLP), detergent micelle, and nanodisc.